REFERENCES
- De Flora S., Balansky R. M., D'Agostini F., Izzotti A., Camoirano A., Bennicelli C., Zhang Z., Wang Y., Lubet R. A., You M. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer Res. 2003; 63(4)793–800
- Doll R., Peto R., Boreham J., Sutherland I. Mortality from cancer in relation to smoking: 50 Years observations on British doctors. Br. J. Cancer 2005; 92(3)426–429
- Foley J. F., Anderson M. W., Stoner G. D., Gaul B. W., Hardisty J. F., Maronpot R. R. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp. Lung Res. 1991; 17(2)157–168
- Helmlinger G., Netti P. A., Lichtenbeld H. C., Melder R. J., Jain R. K. Solid stress inhibits the growth of multicellular tumor spheroids. Nat. Biotechnol. 1997; 15(8)778–783
- Herzog C. R., Lubet R. A., You M. Genetic alterations in mouse lung tumors: Implications for cancer chemoprevention. J. Cell Biochem. Suppl. 1997; 29: 49–63
- Hwang S. J., Cheng L. S., Lozano G., Amos C. I., Gu X., Strong L. C. Lung cancer risk in germline p53 mutation carriers: Association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum. Genet. 2003; 113(3)238–243
- Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R. T., Umanoff H., Edelmann W., Kucherlapati R., Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 1997; 11(19)2468–2481
- Levin L. I., Zheng W., Blot W. J., Gao Y. T., Fraumeni J. F., Jr. Occupation and lung cancer in Shanghai: A case-control study. Br. J. Ind. Med. 1988; 45(7)450–458
- Malkinson A. M. Primary lung tumors in mice: An experimentally manipulable model of human adenocarcinoma. Cancer Res. 1992; 52: 2670s–2676s, (9 suppl.)
- Markel P., Shu P., Ebeling C., Carlson G. A., Nagle D. L., Smutko J. S., Moore K. J. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat. Genet. 1997; 17(3)280–284
- Minna J. D. The molecular biology of lung cancer pathogenesis. Chest 1993; 103: 449S–456S, (4 suppl.)
- Minna J. D., Roth J. A., Gazdar A. F. Focus on lung cancer. Cancer Cell 2002; 1(1)49–52
- Vineis P., Alavanja M., Buffler P., Fontham E., Franceschi S., Gao Y. T., Gupta P. C., Hackshaw A., Matos E., Samet J., Sitas F., Smith J., Stayner L., Straif K., Thun M. J., Wichmann H. E., Wu A. H., Zaridze D., Peto R., Doll R. Tobacco and cancer: Recent epidemiological evidence. JNCI 2004; 96(2)99–106
- Wang Y., Zhang Z., Lubet R., You M. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf. Oncogene 2005; 24(18)3042–3049
- Witschi H. Successful and not so successful chemoprevention of tobacco smoke-induced lung tumors. Exp. Lung Res. 2000; 26(8)743–755
- Witschi H., Espiritu I., Dance S. T., Miller M. S. A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol. Sci. 2002; 68(2)322–330
- Witschi H., Uyeminami D., Moran D., Espiritu I. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure. Carcinogenesis 2000; 21(5)977–982
- Wynder E. L., Graham E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; A study of 684 proved cases. J. Am. Med. Assoc. 1950; 143(4)329–336
- You M., Bergman G. Preclinical and clinical models of lung cancer chemoprevention. Hematol. Oncol. Clin. North Am. 1998; 12(5)1037–1053
- Zhang Z., Li J., Lantry L. E., Wang Y., Wiseman R. W., Lubet R. A., You M. p53 transgenic mice are highly susceptible to 1,2-dimethylhydrazine-induced uterine sarcomas. Cancer Res. 2002; 62(11)3024–3029
- Zhang Z., Liu Q., Lantry L. E., Wang Y., Kelloff G. J., Anderson M. W., Wiseman R. W., Lubet R. A., You M. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Re.s 2000; 60(4)901–907
- Zhang Z., Wang Y., Vikis H. G., Johnson L., Liu G., Li J., Anderson M. W., Sills R. C., Hong H. L., Devereux T. R., Jacks T., Guan K. L., You M. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 2001; 29(1)25–33